Recombinant Streptococcus equi subsp. equi ATP synthase subunit beta (atpD)

What is ATP synthase subunit beta (atpD) in Streptococcus equi and what is its significance?

ATP synthase subunit beta (atpD) is a critical component of the F1F0-ATP synthase complex in Streptococcus equi subspecies equi, the causative agent of equine strangles. This protein plays an essential role in bacterial energy metabolism by catalyzing ATP synthesis through oxidative phosphorylation. The atpD gene encodes this highly conserved protein that contains nucleotide-binding domains and is directly involved in ATP synthesis and hydrolysis.

The significance of atpD lies in its essential function for bacterial survival and potential role in virulence. As demonstrated with other bacterial pathogens, ATP production is crucial during various stages of infection, particularly in nutrient-limited environments. In Chlamydia, for example, ATP production capabilities were found to be important in the early and late stages of the developmental cycle .

How conserved is the atpD gene across Streptococcus species?

The atpD gene is highly conserved across Streptococcus species, making it a useful target for phylogenetic analysis and species identification. Sequence analysis shows:

What are the structural characteristics of S. equi atpD protein?

S. equi atpD protein shares the common structural features of bacterial ATP synthase beta subunits, including:

• An N-terminal domain containing a Walker A motif (P-loop) involved in nucleotide binding

• A central domain containing catalytic residues

• A C-terminal domain involved in subunit interactions within the F1 complex

The protein is approximately 52 kDa and contains highly conserved amino acid sequences at the ATP-binding sites. Homology modeling based on related bacterial ATP synthases suggests the presence of specific binding pockets that could be targeted for antimicrobial development.

What expression systems are most effective for producing recombinant S. equi atpD protein?

Several expression systems can be employed for recombinant S. equi atpD production, with varying advantages:

For structural studies requiring high yields, E. coli systems are preferred. Based on experience with other S. equi proteins, the IMPACT system (New England Biolabs) can be particularly effective, as was demonstrated for the SFS protein from S. equi in previous research .

What is the recommended purification strategy for recombinant S. equi atpD?

A multi-step purification approach typically yields the best results:

• Initial Capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin if His-tagged, or specialized affinity methods such as those used for albumin-binding protein fusions similar to the EAG4B protein

• Intermediate Purification: Ion-exchange chromatography (IEX) using a strong anion exchanger (e.g., Q Sepharose) at pH 8.0

• Polishing Step: Size exclusion chromatography (Superdex 200) in a buffer containing 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM MgCl₂, and 1 mM DTT

For intein fusion systems, specific cleavage conditions are critical. For example, when purifying recombinant S. equi proteins using intein fusion systems, dithiothreitol-induced cleavage must be carefully optimized, as problems with inefficient cleavage have been reported .

How can I verify the correct folding and activity of recombinant atpD protein?

Multiple complementary approaches should be used to confirm proper folding and activity:

• Structural Assessment:

  • Circular dichroism (CD) spectroscopy to evaluate secondary structure

  • Thermal shift assays to assess protein stability

  • Limited proteolysis to examine domain organization

• Functional Assays:

  • ATP hydrolysis activity using a coupled enzyme assay (NADH oxidation)

  • Measurement of phosphate release using malachite green

  • ATPase activity with Km and Vmax determination under varying conditions

• Interaction Analysis:

  • Native PAGE to assess oligomeric state

  • Surface plasmon resonance (SPR) to measure binding to other F1F0 subunits

  • Pull-down assays to verify interactions with other ATP synthase components

When optimizing functional assays, comparative analysis with the E. coli ATP synthase beta subunit can serve as a useful control, similar to approaches used in complementation studies for other bacterial metabolic enzymes .

How can recombinant S. equi atpD be used in vaccine development against strangles?

Recombinant atpD protein shows potential as a vaccine candidate against S. equi infections (strangles) based on several factors:

• Conservation and Essentiality: The highly conserved nature and essential function of atpD make it a stable antigen target that the pathogen cannot easily modify without fitness costs

• Immunogenicity Assessment:

  • Measure antibody responses in convalescent horses using ELISA techniques similar to those used for other S. equi antigens

  • Assess IgG and IgA responses in serum and mucosal samples

• Vaccine Formulation Strategies:

  • Subunit vaccines using purified recombinant atpD with appropriate adjuvants

  • DNA vaccines encoding atpD

  • Combination with other established protective antigens (FNZ, SFS, EAG) that have shown protection in mouse models

• Protection Assessment:

  • Challenge studies in mouse models of S. equi infection

  • Measurement of bacterial colonization and clearance

  • Evaluation of antibody titers and cellular immune responses

The approach to vaccine development would be similar to that used for other S. equi antigens, where recombinant proteins were used to immunize mice either subcutaneously or intranasally prior to nasal challenge with S. equi . The potential of atpD as a vaccine component would need to be assessed alongside established protective antigens.

What role does atpD play in S. equi virulence and pathogenesis?

The role of atpD in S. equi virulence involves several mechanisms:

• Energy Production for Virulence Factor Expression:

  • ATP synthesis is critical for producing energy-dependent virulence factors

  • Enables expression of surface proteins involved in host colonization

• Survival During Infection:

  • Contributes to bacterial persistence in nutrient-limited host environments

  • Supports growth and division during various stages of infection

• Potential Immunomodulatory Effects:

  • Possible interactions with host immune components

  • May contribute to immune evasion strategies

• Association with Stress Response:

  • ATP levels regulate stress response pathways critical during infection

  • May coordinate metabolic adaptation to changing host environments

Research approaches to study these connections include gene knockdown (complete knockout is likely lethal), site-directed mutagenesis of catalytic residues, and in vivo infection models with atpD mutants.

How does S. equi atpD differ functionally from homologs in other bacterial species?

While the core catalytic function of ATP synthesis is conserved, S. equi atpD shows specific adaptations:

These differences may relate to the specific niche adaptation of S. equi to equine hosts and its pathogenic lifestyle. Similar functional differences have been observed for other metabolic enzymes across bacterial species, such as the glycolytic enzymes in Chlamydia that were shown to complement E. coli mutants when expressed recombinantly .

Why might recombinant S. equi atpD show low expression levels?

Several factors can contribute to low expression of recombinant S. equi atpD:

• Codon Usage Bias:

  • S. equi genes often contain rare codons for E. coli

  • Solution: Use codon-optimized synthetic genes or specialized E. coli strains (Rosetta)

• Protein Toxicity:

  • ATPase activity may disrupt E. coli energy metabolism

  • Solution: Use tightly controlled expression systems or catalytically inactive mutants

• mRNA Secondary Structure:

  • Strong secondary structures near the start codon can inhibit translation

  • Solution: Modify 5' sequences while maintaining protein sequence

• Protein Instability:

  • Rapid degradation by host proteases

  • Solution: Co-express with chaperones or use protease-deficient strains

Expression optimization strategies should include screening multiple constructs with different fusion tags and expression conditions, similar to approaches used for other challenging streptococcal proteins .

What strategies can be used to improve the solubility of recombinant S. equi atpD?

Improving solubility of recombinant atpD can be achieved through:

• Expression Condition Optimization:

  • Lower induction temperature (16-20°C)

  • Reduced inducer concentration

  • Extended expression time (24-48 hours)

• Buffer Composition Adjustments:

  • Include stabilizing agents (glycerol 5-10%, trehalose)

  • Add specific ions (Mg²⁺, K⁺) that stabilize ATP synthase

  • Test detergents (0.05-0.1% non-ionic) for partial membrane association

• Fusion Tag Selection:

  • MBP or SUMO tags often improve solubility

  • Thioredoxin fusion for proteins with disulfide bonds

• Co-expression Strategies:

  • Co-express with other ATP synthase subunits for complex formation

  • Add molecular chaperones (GroEL/ES, DnaK/J)

Successful approaches for other S. equi proteins have included the use of specialized expression systems like the IMPACT system, which was used effectively for the SFS protein .

How can the stability of purified recombinant atpD be optimized for long-term storage?

For optimal stability during storage:

• Buffer Composition:

  • 20 mM HEPES or Tris-HCl (pH 7.5-8.0)

  • 150-200 mM NaCl

  • 5 mM MgCl₂ (stabilizes nucleotide-binding proteins)

  • 1-5 mM DTT or 0.5 mM TCEP (prevents oxidation)

  • 10% glycerol (cryoprotectant)

• Storage Conditions:

  • Flash-freeze aliquots in liquid nitrogen

  • Store at -80°C for long-term stability

  • Avoid repeated freeze-thaw cycles

• Stability Enhancers:

  • Addition of ATP or non-hydrolyzable analogs (AMP-PNP)

  • Protein-specific stabilizing agents determined by thermal shift assays

  • Lyophilization with appropriate excipients for room temperature storage

• Quality Control Measures:

  • Regular activity testing of stored samples

  • SEC-MALS analysis to monitor oligomeric state

  • Thermal stability assessment via DSF

These approaches have been successfully applied to other recombinant streptococcal proteins with similar stability challenges .

How can recombinant S. equi atpD be used for studying antimicrobial resistance mechanisms?

Recombinant atpD can provide insights into antimicrobial resistance through:

• Target Site Analysis:

  • Structural studies of atpD interactions with antimicrobials

  • Identification of binding sites for ATP synthase inhibitors

• Resistance Mutation Mapping:

  • Introduction of mutations observed in resistant strains

  • Assessment of functional and structural consequences

• Drug Screening Applications:

  • Development of atpD-based assays for screening novel antimicrobials

  • Structure-guided design of ATP synthase inhibitors

• Correlation with Clinical Observations:

  • Comparison of atpD sequence/function with resistance profiles

  • Assessment of target site modifications in clinical isolates

This research direction is particularly relevant given the increasing concern about antimicrobial resistance in Streptococcus species, as highlighted in studies of falsely reported resistance patterns in S. zooepidemicus .

What is the potential for using S. equi atpD in structural vaccinology approaches?

Structural vaccinology using atpD involves:

• Epitope Mapping:

  • Identification of immunogenic regions through computational prediction and experimental validation

  • B-cell and T-cell epitope characterization

• Structure-Based Design:

  • 3D structure determination through X-ray crystallography or cryo-EM

  • Design of optimized immunogens based on exposed epitopes

• Multi-Epitope Constructs:

  • Engineering chimeric proteins containing key epitopes from atpD and other protective antigens

  • Similar to approaches successfully used with other S. equi antigens like FNZ, SFS, and EAG

• Rational Adjuvant Selection:

  • Structure-guided selection of adjuvants that enhance presentation of key epitopes

  • Testing mucosal vs. systemic delivery systems

This approach could build upon the successful immunization strategies described for other S. equi proteins, where recombinant antigens provided protection in mouse models of infection .

How should controls be designed for experiments involving recombinant S. equi atpD?

Robust experimental design requires appropriate controls:

• Positive Controls:

  • Well-characterized ATP synthase from model organisms (E. coli)

  • Native ATP synthase complex isolated from S. equi

  • Previously validated recombinant protein with similar characteristics

• Negative Controls:

  • Catalytically inactive mutant (mutation in Walker A or B motif)

  • Heat-denatured protein

  • Unrelated protein purified by identical methods

• Expression Controls:

  • Empty vector controls for expression systems

  • Non-relevant protein expressed under identical conditions

  • Time-course samples to monitor expression kinetics

• Experimental Validation:

  • Include known inhibitors of ATP synthase in functional assays

  • Use orthogonal methods to confirm key findings

  • Incorporate internal standards for quantitative measurements

When studying immunological properties, researchers should compare responses to atpD with those of established immunogenic proteins like FNZ, SFS, and EAG that have demonstrated protective efficacy in animal models .

What methodologies can be used to study the interaction of S. equi atpD with other ATP synthase subunits?

Several complementary approaches can elucidate subunit interactions:

• Co-Immunoprecipitation:

  • Use anti-atpD antibodies to pull down associated subunits

  • Mass spectrometry identification of interaction partners

  • Comparative analysis of different growth or stress conditions

• Bacterial Two-Hybrid Systems:

  • Systematic screening of interactions between atpD and other subunits

  • Mapping of specific interaction domains

  • Testing effects of mutations on interaction strength

• Surface Plasmon Resonance:

  • Quantitative measurement of binding kinetics

  • Determination of affinity constants

  • Competition assays with ATP synthase inhibitors

• Cryo-EM and Structural Analysis:

  • Visualization of the complete ATP synthase complex

  • Localization of atpD within the native complex

  • Conformational changes during catalytic cycle

These approaches have been successfully applied to study protein-protein interactions in other streptococcal species, especially for surface proteins involved in adhesion and colonization .